BusinessLegalPipelineResearchEventsProducts
Browse All Stories »
FEATURED
FDA rejects Sydnexis’ NDA for low-dose atropine drop

FDA rejects Sydnexis’ NDA for low-dose atropine drop

SYD-101 still has the potential to become the first pharmaceutical option for progressive myopia for patients aged 3 to 14.

Earn FREE CE 24/7 with Courses by Eyes On Eyecare

Check it out

Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.

TRENDING
Videos
Newton (formerly Neurolens) celebrates new Sequel lens technology
Newton (formerly Neurolens) celebrates new Sequel lens technology
CSI Dry Eye Software releases update for AI-based clinical platform
CSI Dry Eye Software releases update for AI-based clinical platform
Ophthalmology Tech Forum to highlight latest trends and advancements
Ophthalmology Tech Forum to highlight latest trends and advancements
Scope Health brings eyelid health to forefront with new PF OPTASE LIFE eye cream
Scope Health brings eyelid health to forefront with new PF OPTASE LIFE eye cream
Watch More
Business
Smartlens raises $5.2 million to advance miLens FDA clearance and launch
Smartlens raises $5.2 million to advance miLens FDA clearance and launch
Lilly to purchase Adverum Biotechnologies
Lilly to purchase Adverum Biotechnologies
Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device
Ciliatech to open US subsidiary supporting clinical advancement of novel glaucoma device
Topcon invests in Sanro Health
Topcon invests in Sanro Health
Research
Atopic dermatitis linked to increased risk for AMD
Atopic dermatitis linked to increased risk for AMD
Lower AMD risk tied to long-term metformin use
Lower AMD risk tied to long-term metformin use
Physical activity tied to decreased glaucoma progression
Physical activity tied to decreased glaucoma progression
Study: DR, DME patients most likely to miss follow-up care
Study: DR, DME patients most likely to miss follow-up care
Pipeline
FDA rejects Sydnexis’ NDA for low-dose atropine drop
FDA rejects Sydnexis’ NDA for low-dose atropine drop
Complement Therapeutics' GA gene therapy IND receives FDA clearance
Complement Therapeutics' GA gene therapy IND receives FDA clearance
Dompé receives FDA priority voucher for NAION intranasal therapy
Dompé receives FDA priority voucher for NAION intranasal therapy
Nanoscope's optogenetic therapy demonstrates visual improvements for Stargardt
Nanoscope's optogenetic therapy demonstrates visual improvements for Stargardt
Products
Newton's Sequel lenses now available through VSP
Newton's Sequel lenses now available through VSP
VEO Ophthalmics and PeriVision launch VisionOne AI VF platform in the US
VEO Ophthalmics and PeriVision launch VisionOne AI VF platform in the US
Haag-Streit USA launches METIS 3D Digital Heads-Up Module
Haag-Streit USA launches METIS 3D Digital Heads-Up Module
FDA approves Glaukos' Epioxa corneal CXL therapy
FDA approves Glaukos' Epioxa corneal CXL therapy
Legal
Regeneron settles with Sandoz over Eylea biosimilar patent infringement lawsuit
Regeneron settles with Sandoz over Eylea biosimilar patent infringement lawsuit
FDA issues Scope Health warning letter over OPTASE ophthalmic products
FDA issues Scope Health warning letter over OPTASE ophthalmic products
National eyecare organizations launch campaign against NEI consolidation
National eyecare organizations launch campaign against NEI consolidation
Minnesota passes OD scope of practice expansion legislation
Minnesota passes OD scope of practice expansion legislation
Archives
Hello 2023 — Weekly Glance
Hello 2023 — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can we treat uveitis without steroids? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Can I have one dilation drop instead of two? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Are those dilation reversal drops available yet? — Weekly Glance
Events
GMAC launches free myopia awareness toolkit for ECPs
GMAC launches free myopia awareness toolkit for ECPs
Registration open for Eyes On 2026
Registration open for Eyes On 2026
Ophthalmology Tech Forum explores next frontier in retina diagnostics and treatment
Ophthalmology Tech Forum explores next frontier in retina diagnostics and treatment
Registration opens for Eyes On Retina 2025
Registration opens for Eyes On Retina 2025
Browse All Stories »